It is a derivative of cindinidinide hydroxyhydrazine taking GPR40； a synthetic drug； a compound used to treat diseases or diseases such as diabetes, insulin resistance, obesity, etc.
The present invention relates to compounds of general formula I, wherein the groups R1, R2 and m are defined as in claim 1, which have valuable pharmacological properties, in particular bind to the GPR40 receptor and modulate its activity. The compounds are suitable for treatment and prevention of diseases which can be influenced by this receptor, such as metabolic diseases, in particular diabetes type 2.COMPUESTOS DERIVADOS DE ÁCIDOS INDANILOXIDIHIDROBENZOFURANILACÉTICOS, AGONISTAS DEL RECEPTOR GPR40； COMPOSIICON FARMACEUTICA； Y SU USO EN EL TRATAMIENTO DE ENFERMEDADES O AFECCIONES COMO DIABETES, RESISTENCIA A LA INSULINA, OBESIDAD, ENTRE OTRAS.
